Published in Women's Health Weekly, November 15th, 2001
It was described at ECCO 11 - the European Cancer Conference in Lisbon, Portugal. The program produces easy-to-read reviews of different treatment options and also forecasts the individual's chances of 10-year survival. It is based on international studies of treatment options and data from U.S. tumor registries highlighting the risk of dying from particular types of breast cancer. This risk is calculated by assessing the nature and size of the tumor and whether or not it shows...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly